发明申请
- 专利标题: 3, 4, 5 - Substituted Piperidine Compounds
- 专利标题(中): 3,4,5 - 取代的哌啶化合物
-
申请号: US11908182申请日: 2006-03-07
-
公开(公告)号: US20100160305A1公开(公告)日: 2010-06-24
- 发明人: Keiichi Masuya , Fumiaki Yokokawa , Osamu Irie , Atsuko Nihonyanagi , Takeru Ehara , Kazuhide Konishi , Takanori Kanazawa , Masaki Suzuki
- 申请人: Keiichi Masuya , Fumiaki Yokokawa , Osamu Irie , Atsuko Nihonyanagi , Takeru Ehara , Kazuhide Konishi , Takanori Kanazawa , Masaki Suzuki
- 申请人地址: CH Basel
- 专利权人: NOVARTIS AG
- 当前专利权人: NOVARTIS AG
- 当前专利权人地址: CH Basel
- 优先权: GB0504850.9 20050309
- 国际申请: PCT/EP2006/002083 WO 20060307
- 主分类号: A61K31/451
- IPC分类号: A61K31/451 ; A61K31/538 ; A61K31/454 ; C07D413/12 ; C07D401/12 ; C07D211/60 ; A61P43/00
摘要:
3,4,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4,5-substituted piperidine compound, a method for the manufacture of a 3,4,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis.The compounds are of the formula I, wherein the substitutents are as defined in the specification.
信息查询
IPC分类: